Page 32 - Sight Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FinancialContent fully hosted finance channel

Investment Analysts’ upgrades for Tuesday, May 31st: Amundi (OTCMKTS:AMDUF) was upgraded by analysts at Keefe, Bruyette & Woods from a market perform rating to an outperform rating. Aperam (OTCMKTS:APEMY) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. China Gas (OTCMKTS:CGHLY) was upgraded by analysts at Daiwa Capital […]

Sight Sciences (NASDAQ:SGHT – Get Rating) is one of 213 public companies in the “Surgical & medical instruments” industry, but how does it compare to its peers? We will compare Sight Sciences to similar companies based on the strength of its institutional ownership, risk, dividends, analyst recommendations, valuation, profitability and earnings. Insider & Institutional Ownership […]

Nuvectra (OTCMKTS:NVTRQ – Get Rating) and Sight Sciences (NASDAQ:SGHT – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings. Analyst Recommendations This is a summary of current ratings and […]

Sight Sciences (NASDAQ:SGHT – Get Rating) is one of 213 public companies in the “Surgical & medical instruments” industry, but how does it contrast to its peers? We will compare Sight Sciences to similar companies based on the strength of its institutional ownership, valuation, profitability, risk, dividends, analyst recommendations and earnings. Insider and Institutional Ownership […]